A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation

被引:74
作者
Cesaro, S. [1 ]
Facchin, C. [1 ]
Tridello, G. [1 ]
Messina, C. [1 ]
Calore, E. [1 ]
Biasolo, M. A. [2 ]
Pillon, M. [1 ]
Varotto, S. [1 ]
Brugiolo, A. [1 ]
Mengoli, C. [2 ]
Palu, G. [2 ]
机构
[1] Univ Padua, Dept Pediat, I-35128 Padua, Italy
[2] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35128 Padua, Italy
关键词
paediatric; malignancy; BK virus infection; haemorrhagic cystitis; haematopoietic stem cell transplantation;
D O I
10.1038/sj.bmt.1705909
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We investigated the incidence, risk factors and outcome of haemorrhagic cystitis ( HC) in paediatric patients undergoing HSCT and the predictive value of BK viruria and viraemia for developing HC. Over a period of 54 months, 74 patients were recruited. The cumulative incidence of HC was 22%. Among 15 patients prospectively monitored for BK viruria and viraemia, four patients developed HC of grade >= II. This group, which had two consecutive BK positive samples, showed a sensitivity of 100%, a specificity of 82%, a positive predictive value of 67%, and negative predictive value of 100% for developing HC. Analysed by a receiver - operator characteristic curve ( ROC), a urine BK load >9 x 10(6) genomic copies/ml had a sensitivity of 95% and specificity of 90%; while a blood BK load >1 x 10(3) genomic copies/ml had a sensitivity of 40% and a specificity of 93% for HC, respectively. In univariate analysis, BK positivity was the only factor significantly associated with HC. After a median follow-up of 1.8 years, patients with HC showed a lower overall survival, 40 vs 65%, P 0.01, and a lower event-free survival, 42 vs 62%, P 0.03, compared to patients without HC. We conclude that BK detection in urine and/or plasma is a specific predictor for developing HC.
引用
收藏
页码:363 / 370
页数:8
相关论文
共 43 条
[1]  
Agresti A., 1990, Analysis of categorical data
[2]   Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation [J].
Akiyama, H ;
Kurosu, T ;
Sakashita, C ;
Inoue, T ;
Mori, S ;
Ohashi, K ;
Tanikawa, S ;
Sakamaki, H ;
Onozawa, Y ;
Chen, Q ;
Zheng, HY ;
Kitamura, T .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1325-1330
[3]   ASSOCIATION OF BK VIRURIA WITH HEMORRHAGIC CYSTITIS IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J].
ARTHUR, RR ;
SHAH, KV ;
BAUST, SJ ;
SANTOS, GW ;
SARAL, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :230-234
[4]  
AZZI A, 1994, BONE MARROW TRANSPL, V14, P235
[5]   Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients [J].
Azzi, A ;
Cesaro, S ;
Laszlo, D ;
Zakrzewska, K ;
Ciappi, S ;
De Santis, R ;
Fanci, R ;
Pesavento, G ;
Calore, E ;
Bosi, A .
JOURNAL OF CLINICAL VIROLOGY, 1999, 14 (02) :79-86
[6]   REGIMEN-RELATED TOXICITY IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
BEARMAN, SI ;
APPELBAUM, FR ;
BUCKNER, CD ;
PETERSEN, FB ;
FISHER, LD ;
CLIFT, RA ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) :1562-1568
[7]   ASSOCIATION OF BK VIRUS WITH FAILURE OF PROPHYLAXIS AGAINST HEMORRHAGIC CYSTITIS FOLLOWING BONE-MARROW TRANSPLANTATION [J].
BEDI, A ;
MILLER, CB ;
HANSON, JL ;
GOODMAN, S ;
AMBINDER, RF ;
CHARACHE, P ;
ARTHUR, RR ;
JONES, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1103-1109
[8]   Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation [J].
Bogdanovic, G ;
Priftakis, P ;
Giraud, G ;
Kuzniar, M ;
Ferraldeschi, R ;
Kokhaei, P ;
Mellstedt, H ;
Remberger, M ;
Ljungman, P ;
Winiarski, J ;
Dalianis, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (11) :5394-5396
[9]   HEMORRHAGIC CYSTITIS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN CHILDREN WITH MALIGNANCIES - INCIDENCE, CLINICAL COURSE, AND OUTCOME [J].
BRUGIERES, L ;
HARTMANN, O ;
TRAVAGLI, JP ;
BENHAMOU, E ;
PICO, JL ;
VALTEAU, D ;
KALIFA, C ;
PATTE, C ;
FLAMANT, F ;
LEMERLE, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :194-199
[10]   Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation [J].
Cesaro, S ;
Zhou, X ;
Manzardo, C ;
Buonfrate, D ;
Cusinato, R ;
Tridello, G ;
Mengoli, C ;
Palù, G ;
Messina, C .
JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (02) :129-132